中文

恩威医药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-27
ItemAmountY/Y
Revenue¥0.18B-10.8%
Gross profit¥0.10B
Operating income¥0.01B
Net income¥0.01B-23.3%
Gross margin55.7%Net margin 7.1%
Revenue Q/Q-33.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.08B44.3%
R&D¥0.00B0.6%
SG&A¥0.08B47.2%
Tax & other¥0.00B0.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

德尔玛诺思格天元宠物趣睡科技亚华电子凯格精机通行宝涛涛车业蓝箭电子信德新材普莱得南王科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies